List of Tables
Table 1. Flow Cytometry in Oncology and Immunology Market Trends
Table 2. Flow Cytometry in Oncology and Immunology Market Drivers & Opportunity
Table 3. Flow Cytometry in Oncology and Immunology Market Challenges
Table 4. Flow Cytometry in Oncology and Immunology Market Restraints
Table 5. Global Flow Cytometry in Oncology and Immunology Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Flow Cytometry in Oncology and Immunology Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Flow Cytometry in Oncology and Immunology Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Flow Cytometry in Oncology and Immunology Product Type
Table 9. Key Companies Time to Begin Mass Production of Flow Cytometry in Oncology and Immunology
Table 10. Global Flow Cytometry in Oncology and Immunology Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Flow Cytometry in Oncology and Immunology as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Flow Cytometry in Oncology and Immunology Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Flow Cytometry in Oncology and Immunology Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Flow Cytometry in Oncology and Immunology Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Flow Cytometry in Oncology and Immunology Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Flow Cytometry in Oncology and Immunology Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Flow Cytometry in Oncology and Immunology Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Flow Cytometry in Oncology and Immunology Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Flow Cytometry in Oncology and Immunology Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Flow Cytometry in Oncology and Immunology Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Flow Cytometry in Oncology and Immunology Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Flow Cytometry in Oncology and Immunology Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Flow Cytometry in Oncology and Immunology Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Flow Cytometry in Oncology and Immunology Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Flow Cytometry in Oncology and Immunology Sales Value by Region (2019-2024) & (%)
Table 27. Global Flow Cytometry in Oncology and Immunology Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Flow Cytometry in Oncology and Immunology Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Flow Cytometry in Oncology and Immunology Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Flow Cytometry in Oncology and Immunology Sales Value, (2025-2030) & (US$ Million)
Table 31. Agilent Basic Information List
Table 32. Agilent Description and Business Overview
Table 33. Agilent Flow Cytometry in Oncology and Immunology Products, Services and Solutions
Table 34. Revenue (US$ Million) in Flow Cytometry in Oncology and Immunology Business of Agilent (2019-2024)
Table 35. Agilent Recent Developments
Table 36. ABYNTEK BIOPHARMA Basic Information List
Table 37. ABYNTEK BIOPHARMA Description and Business Overview
Table 38. ABYNTEK BIOPHARMA Flow Cytometry in Oncology and Immunology Products, Services and Solutions
Table 39. Revenue (US$ Million) in Flow Cytometry in Oncology and Immunology Business of ABYNTEK BIOPHARMA (2019-2024)
Table 40. ABYNTEK BIOPHARMA Recent Developments
Table 41. Bio-Rad Laboratories Basic Information List
Table 42. Bio-Rad Laboratories Description and Business Overview
Table 43. Bio-Rad Laboratories Flow Cytometry in Oncology and Immunology Products, Services and Solutions
Table 44. Revenue (US$ Million) in Flow Cytometry in Oncology and Immunology Business of Bio-Rad Laboratories (2019-2024)
Table 45. Bio-Rad Laboratories Recent Developments
Table 46. Cell Signaling Technology Basic Information List
Table 47. Cell Signaling Technology Description and Business Overview
Table 48. Cell Signaling Technology Flow Cytometry in Oncology and Immunology Products, Services and Solutions
Table 49. Revenue (US$ Million) in Flow Cytometry in Oncology and Immunology Business of Cell Signaling Technology (2019-2024)
Table 50. Cell Signaling Technology Recent Developments
Table 51. Cytek Biosciences Basic Information List
Table 52. Cytek Biosciences Description and Business Overview
Table 53. Cytek Biosciences Flow Cytometry in Oncology and Immunology Products, Services and Solutions
Table 54. Revenue (US$ Million) in Flow Cytometry in Oncology and Immunology Business of Cytek Biosciences (2019-2024)
Table 55. Cytek Biosciences Recent Developments
Table 56. Danaher Corporation, Basic Information List
Table 57. Danaher Corporation, Description and Business Overview
Table 58. Danaher Corporation, Flow Cytometry in Oncology and Immunology Products, Services and Solutions
Table 59. Revenue (US$ Million) in Flow Cytometry in Oncology and Immunology Business of Danaher Corporation, (2019-2024)
Table 60. Danaher Corporation, Recent Developments
Table 61. DiaSorin S.p.A (Luminex Corporation), Basic Information List
Table 62. DiaSorin S.p.A (Luminex Corporation), Description and Business Overview
Table 63. DiaSorin S.p.A (Luminex Corporation), Flow Cytometry in Oncology and Immunology Products, Services and Solutions
Table 64. Revenue (US$ Million) in Flow Cytometry in Oncology and Immunology Business of DiaSorin S.p.A (Luminex Corporation), (2019-2024)
Table 65. DiaSorin S.p.A (Luminex Corporation), Recent Developments
Table 66. Enzi Biochem Inc Basic Information List
Table 67. Enzi Biochem Inc Description and Business Overview
Table 68. Enzi Biochem Inc Flow Cytometry in Oncology and Immunology Products, Services and Solutions
Table 69. Revenue (US$ Million) in Flow Cytometry in Oncology and Immunology Business of Enzi Biochem Inc (2019-2024)
Table 70. Enzi Biochem Inc Recent Developments
Table 71. Laboratory Corporation of America Holdings, Basic Information List
Table 72. Laboratory Corporation of America Holdings, Description and Business Overview
Table 73. Laboratory Corporation of America Holdings, Flow Cytometry in Oncology and Immunology Products, Services and Solutions
Table 74. Revenue (US$ Million) in Flow Cytometry in Oncology and Immunology Business of Laboratory Corporation of America Holdings, (2019-2024)
Table 75. Laboratory Corporation of America Holdings, Recent Developments
Table 76. Merck KGaA Basic Information List
Table 77. Merck KGaA Description and Business Overview
Table 78. Merck KGaA Flow Cytometry in Oncology and Immunology Products, Services and Solutions
Table 79. Revenue (US$ Million) in Flow Cytometry in Oncology and Immunology Business of Merck KGaA (2019-2024)
Table 80. Merck KGaA Recent Developments
Table 81. Miltenyi Biotec Basic Information List
Table 82. Miltenyi Biotec Description and Business Overview
Table 83. Miltenyi Biotec Flow Cytometry in Oncology and Immunology Products, Services and Solutions
Table 84. Revenue (US$ Million) in Flow Cytometry in Oncology and Immunology Business of Miltenyi Biotec (2019-2024)
Table 85. Miltenyi Biotec Recent Developments
Table 86. NeoGenomics Laboratories Basic Information List
Table 87. NeoGenomics Laboratories Description and Business Overview
Table 88. NeoGenomics Laboratories Flow Cytometry in Oncology and Immunology Products, Services and Solutions
Table 89. Revenue (US$ Million) in Flow Cytometry in Oncology and Immunology Business of NeoGenomics Laboratories (2019-2024)
Table 90. NeoGenomics Laboratories Recent Developments
Table 91. OPKO Health Basic Information List
Table 92. OPKO Health Description and Business Overview
Table 93. OPKO Health Flow Cytometry in Oncology and Immunology Products, Services and Solutions
Table 94. Revenue (US$ Million) in Flow Cytometry in Oncology and Immunology Business of OPKO Health (2019-2024)
Table 95. OPKO Health Recent Developments
Table 96. Sony Group Corporation Basic Information List
Table 97. Sony Group Corporation Description and Business Overview
Table 98. Sony Group Corporation Flow Cytometry in Oncology and Immunology Products, Services and Solutions
Table 99. Revenue (US$ Million) in Flow Cytometry in Oncology and Immunology Business of Sony Group Corporation (2019-2024)
Table 100. Sony Group Corporation Recent Developments
Table 101. Thermo Fisher Scientific Inc. Basic Information List
Table 102. Thermo Fisher Scientific Inc. Description and Business Overview
Table 103. Thermo Fisher Scientific Inc. Flow Cytometry in Oncology and Immunology Products, Services and Solutions
Table 104. Revenue (US$ Million) in Flow Cytometry in Oncology and Immunology Business of Thermo Fisher Scientific Inc. (2019-2024)
Table 105. Thermo Fisher Scientific Inc. Recent Developments
Table 106. Key Raw Materials Lists
Table 107. Raw Materials Key Suppliers Lists
Table 108. Flow Cytometry in Oncology and Immunology Downstream Customers
Table 109. Flow Cytometry in Oncology and Immunology Distributors List
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
Table 113. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Flow Cytometry in Oncology and Immunology Product Picture
Figure 2. Global Flow Cytometry in Oncology and Immunology Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Flow Cytometry in Oncology and Immunology Sales Value (2019-2030) & (US$ Million)
Figure 4. Flow Cytometry in Oncology and Immunology Report Years Considered
Figure 5. Global Flow Cytometry in Oncology and Immunology Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Flow Cytometry in Oncology and Immunology Revenue in 2023
Figure 7. Flow Cytometry in Oncology and Immunology Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Products Picture
Figure 9. Services Picture
Figure 10. Global Flow Cytometry in Oncology and Immunology Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global Flow Cytometry in Oncology and Immunology Sales Value Market Share by Type, 2023 & 2030
Figure 12. Product Picture of Immunology
Figure 13. Product Picture of Oncology
Figure 14. Product Picture of Solid Tumor
Figure 15. Global Flow Cytometry in Oncology and Immunology Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Flow Cytometry in Oncology and Immunology Sales Value Market Share by Application, 2023 & 2030
Figure 17. North America Flow Cytometry in Oncology and Immunology Sales Value (2019-2030) & (US$ Million)
Figure 18. North America Flow Cytometry in Oncology and Immunology Sales Value by Country (%), 2023 VS 2030
Figure 19. Europe Flow Cytometry in Oncology and Immunology Sales Value (2019-2030) & (US$ Million)
Figure 20. Europe Flow Cytometry in Oncology and Immunology Sales Value by Country (%), 2023 VS 2030
Figure 21. Asia Pacific Flow Cytometry in Oncology and Immunology Sales Value (2019-2030) & (US$ Million)
Figure 22. Asia Pacific Flow Cytometry in Oncology and Immunology Sales Value by Country (%), 2023 VS 2030
Figure 23. South America Flow Cytometry in Oncology and Immunology Sales Value (2019-2030) & (US$ Million)
Figure 24. South America Flow Cytometry in Oncology and Immunology Sales Value by Country (%), 2023 VS 2030
Figure 25. Middle East & Africa Flow Cytometry in Oncology and Immunology Sales Value (2019-2030) & (US$ Million)
Figure 26. Middle East & Africa Flow Cytometry in Oncology and Immunology Sales Value by Country (%), 2023 VS 2030
Figure 27. Key Countries/Regions Flow Cytometry in Oncology and Immunology Sales Value (%), (2019-2030)
Figure 28. United States Flow Cytometry in Oncology and Immunology Sales Value, (2019-2030) & (US$ Million)
Figure 29. United States Flow Cytometry in Oncology and Immunology Sales Value by Type (%), 2023 VS 2030
Figure 30. United States Flow Cytometry in Oncology and Immunology Sales Value by Application (%), 2023 VS 2030
Figure 31. Europe Flow Cytometry in Oncology and Immunology Sales Value, (2019-2030) & (US$ Million)
Figure 32. Europe Flow Cytometry in Oncology and Immunology Sales Value by Type (%), 2023 VS 2030
Figure 33. Europe Flow Cytometry in Oncology and Immunology Sales Value by Application (%), 2023 VS 2030
Figure 34. China Flow Cytometry in Oncology and Immunology Sales Value, (2019-2030) & (US$ Million)
Figure 35. China Flow Cytometry in Oncology and Immunology Sales Value by Type (%), 2023 VS 2030
Figure 36. China Flow Cytometry in Oncology and Immunology Sales Value by Application (%), 2023 VS 2030
Figure 37. Japan Flow Cytometry in Oncology and Immunology Sales Value, (2019-2030) & (US$ Million)
Figure 38. Japan Flow Cytometry in Oncology and Immunology Sales Value by Type (%), 2023 VS 2030
Figure 39. Japan Flow Cytometry in Oncology and Immunology Sales Value by Application (%), 2023 VS 2030
Figure 40. South Korea Flow Cytometry in Oncology and Immunology Sales Value, (2019-2030) & (US$ Million)
Figure 41. South Korea Flow Cytometry in Oncology and Immunology Sales Value by Type (%), 2023 VS 2030
Figure 42. South Korea Flow Cytometry in Oncology and Immunology Sales Value by Application (%), 2023 VS 2030
Figure 43. Southeast Asia Flow Cytometry in Oncology and Immunology Sales Value, (2019-2030) & (US$ Million)
Figure 44. Southeast Asia Flow Cytometry in Oncology and Immunology Sales Value by Type (%), 2023 VS 2030
Figure 45. Southeast Asia Flow Cytometry in Oncology and Immunology Sales Value by Application (%), 2023 VS 2030
Figure 46. India Flow Cytometry in Oncology and Immunology Sales Value, (2019-2030) & (US$ Million)
Figure 47. India Flow Cytometry in Oncology and Immunology Sales Value by Type (%), 2023 VS 2030
Figure 48. India Flow Cytometry in Oncology and Immunology Sales Value by Application (%), 2023 VS 2030
Figure 49. Flow Cytometry in Oncology and Immunology Industrial Chain
Figure 50. Flow Cytometry in Oncology and Immunology Manufacturing Cost Structure
Figure 51. Channels of Distribution (Direct Sales, and Distribution)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
